Efficacy News and Research

RSS
Abbott submits SIMCOR sNDA for two new dosage strengths

Abbott submits SIMCOR sNDA for two new dosage strengths

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

Targacept commences TC-5619 Phase 2 study of cognitive dysfunction in schizophrenia

Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC

Merck commences Stimuvax Phase 3 trial in Asian patients with NSCLC

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

YM BioSciences announces results of collaborative antibody development program

YM BioSciences announces results of collaborative antibody development program

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Cell transplants may yield new therapies for dementia patients

Cell transplants may yield new therapies for dementia patients

Medifocus begins common stock trading on OTC Pink Sheets market

Medifocus begins common stock trading on OTC Pink Sheets market

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

BIOGUARD barrier gauze dressings offer high antiviral efficacy against H1N1

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Cardiologists receive K23 research grant from NIH

Cardiologists receive K23 research grant from NIH

Initiation of dose-finding study to evaluate safety and efficacy of MP4OX treatment

Initiation of dose-finding study to evaluate safety and efficacy of MP4OX treatment

Second pivotal Phase 3 trial to evaluate investigational Lp-PLA2 inhibitor darapladib initiated

Second pivotal Phase 3 trial to evaluate investigational Lp-PLA2 inhibitor darapladib initiated

Additional data from ALS patients enrolled in confirmatory Phase III STAR trial announced

Additional data from ALS patients enrolled in confirmatory Phase III STAR trial announced

Decision Resources reports increased uptake of TNF-alpha inhibitors for Crohn's disease

Decision Resources reports increased uptake of TNF-alpha inhibitors for Crohn's disease

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Preliminary data from Phase 2 clinical trial of ZFP Therapeutic program presented

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Clinical trial results demonstrate greater efficacy of nilotinib over imatinib for Ph+ CML

Rats exposed to passive smoking become dependent on nicotine, reveals study

Rats exposed to passive smoking become dependent on nicotine, reveals study

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

Recruitment complete in Oxagen's OC000459 IIb clinical trial for asthma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.